Hokkaido University · Faculty of Pharmaceutical Sciences / Graduate School of Pharmaceutical Sciences · 助教

Research keywords銇屻倱骞圭窗鑳・绱拌優澶栧皬鑳・鑲濈窗鑳炵檶・MSC・Internal・medicine・Gastroenterology・Hepatocellular

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease.2026 · Frontiers in nutrition, 13, 1730695, 1730695, 2026年,
• Tenofovir alafenamide prevents HBV reactivation in anticancer/immunosuppression: 24-month multicentre prospective study.2026 · The Journal of infection, 92, 4, 106715, 106715, 2026年04月,
• Cirrhotic Cardiomyopathy: Prevalence and Clinical Impact on Liver Cirrhosis Outcomes.2025 · Hepatology research : the official journal of the Japan Society of Hepatology, 2025年06月19日,
• Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC.2025 · JHEP reports : innovation in hepatology, 7, 5, 101364, 101364, 2025年05月,

• 肝細胞癌幹細胞における免疫チェックポイント分子の発現機構の解明
• メトホルミンによるがん幹細胞マーカーＣＤ１３３発現抑制機構の解明
• 食道扁平上皮癌がん幹細胞における免疫逃避機構の解明
• 肝細胞癌幹細胞におけるレンバチニブ耐性機構の解明

• Official profile